Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 10/20 | 0.76 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.76 |
| ▸ | LMNA | P02545 | 3/20 | 0.76 |
| ▸ | TSHR | P16473 | 2/20 | 0.76 |
| ▸ | HTR1A | P08908 | 1/20 | 0.76 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.76 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.76 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.76 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.76 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.74 |
| ▸ | CASP7 | P55210 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mabuterol SCHEMBL123796 | 0.99 | LMNA (0.77) | ADRB2ADRB1LMNATSHRHTR1A | |
| Mabuterol SCHEMBL29384375 | 0.99 | LMNA (0.77) | ADRB2ADRB1LMNATSHRHTR1A | |
| Mabuterol SCHEMBL29576601 | 0.91 | ADRB2 (0.63) | ADRB2ADRB1LMNATSHRHTR1A | |
| SCHEMBL11026998 | 0.88 | ADRB2 (0.59) | ADRB2ADRB1LMNATSHRHTR1A | |
| SCHEMBL4882139 | 0.88 | ADRB2 (0.59) | ADRB2ADRB1LMNATSHRHTR1A | |
| Mabuterol SCHEMBL21623862 | 0.88 | ADRB2 (0.59) | ADRB2ADRB1LMNATSHRHTR1A | |
| Hydrochloric Acid SCHEMBL11054918 | 0.87 | LMNA (0.60) | ADRB2ADRB1LMNATSHRHTR1A | |
| Clenbuterol SCHEMBL4722 | 0.87 | ADRB1 (1.00) | ADRB2ADRB1LMNATSHRHTR1A | |
| Clenbuterol SCHEMBL20761507 | 0.87 | ADRB1 (1.00) | ADRB2ADRB1LMNATSHRHTR1A | |
| Clenbuterol SCHEMBL4723 | 0.87 | ADRB1 (1.00) | ADRB2ADRB1LMNATSHRHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3829 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20250134835-A1 | COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) | CURASEN THERAPEUTICS, INC. | 2025-05-01 | — | — | US | claimed |
| US-20250017878-A1 | USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY | CHRONIC AIRWAY THERAPEUTICS LTD (AU) | 2025-01-16 | — | — | US | claimed |
| US-20240398729-A1 | Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage Disorders | DUKE UNIVERSITY (US) | 2024-12-05 | — | — | US | claimed |
| EP-4126138-B1 | AEROSOL DELIVERY OF AT LEAST TWO LIQUID COMPOSITIONS | INVOX BELGIUM NV (BE) | 2024-10-16 | — | — | EP | claimed |
| US-20240325413-A1 | FORMULATIONS FOR THE TREATMENT OF RESPIRATORY DISORDERS | 484 SCIENCE CORP (CA) | 2024-10-03 | — | — | US | claimed |
| WO-2024189434-A1 | USE OF NADOLOL TO TREAT PULMONARY SYMPTOMS ASSOCIATED WITH INFECTIONS WITH SARS-CoV-2 | CHRONIC AIRWAY THERAPEUTICS LIMITED (AU) | 2024-09-19 | — | — | WO | claimed |
| US-20240270855-A1 | NEURO-MESENCHYME UNITS CONTROL ILC2 AND OBESITY VIA A BRAIN-ADIPOSE CIRCUIT | FUNDAÇÃO D. ANNA DE SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD (PT) | 2024-08-15 | — | — | US | claimed |
| WO-2024137478-A1 | METHODS FOR TREATING VARIOUS CONDITIONS AND INDICATIONS WITH AGONISTS AND ANTAGONISTS | CURASEN THERAPEUTICS, INC. (US) | 2024-06-27 | — | — | WO | claimed |
| US-20240189244-A1 | COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICAL AGENTS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2024-06-13 | — | — | US | claimed |
| WO-1996019198-A1 | AEROSOL DRUG FORMULATIONS | ASTRA AKTIEBOLAG (SE) | 1996-06-27 | — | — | WO | claimed |
| US-5312627-A | Polymer matrix with drugs with bronchodilator agents | ZAMBON GROUP S.P.A. (IT) | 1994-05-17 | — | — | US | claimed |
| EP-0523537-A1 | Transdermal therapeutic system for the administration of drugs having bronchodilating activity | ZAMBON GROUP S.p.A. (IT) | 1993-01-20 | — | — | EP | claimed |
| EP-0341559-A2 | Synergistic mixtures and their therapeutical use | BOEHRINGER INGELHEIM KG (DE) | 1989-11-15 | — | — | EP | claimed |
| EP-0338507-A2 | Use of mabuterol and related compounds for intraocular pressure adjustment | Basotherm GmbH (DE) | 1989-10-25 | — | — | EP | claimed |
| EP-0298984-A1 | COMPOSITIONS OF LIPOSOMES AND $g(b) 2?-RECEPTOR ACTIVE SUBSTANCES | Aktiebolaget Draco (SE) | 1989-01-18 | — | — | EP | claimed |
| WO-1987005803-A1 | COMPOSITIONS OF LIPOSOMES AND beta2-RECEPTOR ACTIVE SUBSTANCES | AKTIEBOLAGET DRACO (SE) | 1987-10-08 | — | — | WO | claimed |
| EP-0201732-A2 | Beta-2-mimetics of the 4-aminophenylethanolamine type for the prevention of peptic ulcers | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 1986-11-20 | — | — | EP | claimed |
| EP-0057900-B1 | ANIMAL FEED ADDITIVE FOR IMPROVING GROWTH | Dr. Karl Thomae GmbH (DE) | 1985-05-08 | — | — | EP | claimed |
| US-4119710-A | ANALGESICS, UTEROSPASMOLYTICS, ANTISPASTICS, BLOCKING AGENTS | BOEHRINGER INGELHEIM GMBH (DE) | 1978-10-10 | — | — | US | claimed |